Alnylam Pharmaceuticals | ALNY - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Acadia Pharmaceuticals USD 4.53B 199M 2026-08
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Amgen USD 209.65B 14.21B 2026-08
Arrowhead Research USD 10.84B 664M 2026-08
BioCryst Pharmaceuticals USD 1.9B 643M 2026-08
BioMarin Pharmaceutical USD 11.71B 651M 2026-08
Incyte USD 26.84B 4.19B 2026-08
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Novartis USD 288.26B 25.18B 2026-03
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Sanofi EUR 113.52B 3.82B 2026-03
Sarepta Therapeutics USD 1.5B 402M 2026-08
Takeda JPY 8.2T 809.7B 2026-06
Tectonic Therapeutic USD 580M 190M 2026-03
Ultragenyx Pharmaceutical USD 2.12B 1.16B 2026-08
Vertex Pharmaceuticals USD 137.33B 11.26B 2026-08
Xencor USD 1.21B 19M 2026-08